{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:52:53Z","timestamp":1791741173034,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41409-020-01183-9","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T18:05:57Z","timestamp":1608141957000},"page":"1291-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Second haploidentical stem cell transplantation for primary graft failure"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1382-5496","authenticated-orcid":false,"given":"Sabrina","family":"Giammarco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Raiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Di Grazia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bregante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gualandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Varaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-1587","authenticated-orcid":false,"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-5298","authenticated-orcid":false,"given":"Federica","family":"Sora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Metafuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idanna","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Autore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Murgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"1183_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transpl. 2017;52:811\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"1183_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1183_CR3","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"DP Lu","year":"2006","unstructured":"Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2006;107:3065\u201373.","journal-title":"Blood"},{"key":"1183_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.imlet.2013.09.027","volume":"155","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Bauquet A, Palumbo, Moretta F, Bertaina A. Negative depletion of \u03b1\/\u03b2+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation. Immunol Lett. 2013;155:21\u20133.","journal-title":"Immunol Lett"},{"issue":"Aug","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood. 2014;124(Aug):843\u201350. 7","journal-title":"Blood"},{"key":"1183_CR6","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","volume":"125","author":"SR McCurdy","year":"2015","unstructured":"McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bola\u00f1os-Meade J, Rosner GL, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 2015;125:3024\u201331.","journal-title":"Blood"},{"key":"1183_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","volume":"57","author":"ZN Ozdemir","year":"2018","unstructured":"Ozdemir ZN, Bozda\u011f SC. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apheresis Sci. 2018;57:163\u20137.","journal-title":"Transfus Apheresis Sci"},{"key":"1183_CR8","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015;29:1754\u201362.","journal-title":"Leukemia"},{"key":"1183_CR9","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.bbmt.2014.05.016","volume":"20","author":"A Stasia","year":"2014","unstructured":"Stasia A, Ghiso A, Galaverna F, Raiola AM, Gualandi F, Luchetti S, et al. CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:1440\u20133.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1183_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00007890-199005000-00020","volume":"49","author":"H Nakamura","year":"1990","unstructured":"Nakamura H, Gress RE. Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrow. Transplantation. 1990;49:453\u20138.","journal-title":"Transplantation"},{"key":"1183_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","volume":"43","author":"NA Kernan","year":"1987","unstructured":"Kernan NA, Flomenberg N, Dupont B, O\u2019Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA- non identical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987;43:842\u20137.","journal-title":"Transplantation"},{"key":"1183_CR12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","volume":"21","author":"SO Ciurea","year":"2015","unstructured":"Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, et al. Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:1392\u20138.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1183_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","volume":"88","author":"SO Ciurea","year":"2009","unstructured":"Ciurea SO, de Lima M, Cano, Korbling M, Giralt S, Shpall EJ, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009;88:1019\u201324. 27","journal-title":"Transplantation"},{"key":"1183_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/bmt.2011.131","volume":"47","author":"S Yoshihara","year":"2012","unstructured":"Yoshihara S, Maruya E, Taniguchi K, Kaida K, Kato R, Inoue T, et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transpl. 2012;47:508\u201315.","journal-title":"Bone Marrow Transpl"},{"key":"1183_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"10","author":"YJ Chang","year":"2015","unstructured":"Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W, et al. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol. 2015;10:84.","journal-title":"J Hematol Oncol"},{"key":"1183_CR16","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","volume":"116","author":"M Takanashi","year":"2010","unstructured":"Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116:2839\u201346.","journal-title":"Blood"},{"key":"1183_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3324\/haematol.2012.077685","volume":"98","author":"A Ruggeri","year":"2013","unstructured":"Ruggeri A, Rocha V, Masson E, Labopin M, Cunha R, Absi L, et al. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Soci\u00e9t\u00e9 Francophone d\u2019Histocompatibilit\u00e9 et d\u2019Immunog\u00e9n\u00e9tique (SFHI) and Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC) analysis. Haematologica. 2013;98:1154\u201360.","journal-title":"Haematologica"},{"key":"1183_CR18","doi-asserted-by":"crossref","unstructured":"Bramanti S, Calafiore V, Longhi E, Mariotti J, Crespiatico L, Sarina B, et al. Donor-specific anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes. Biol Blood Marrow Transpl. 2019;25:1395\u201346.","DOI":"10.1016\/j.bbmt.2019.02.020"},{"key":"1183_CR19","doi-asserted-by":"crossref","unstructured":"Prata PH, Resche-Rigon M, Blaise D, Soci\u00e9 G, Rohrlich PS, Milpied N, et al. Outcomes of salvage haploidentical transplant with post-transplant cyclophosphamide for rescuing graft failure patients: a report on behalf of the francophone society of bone marrow transplantation and cellular therapy. Biol Blood Marrow Transpl. 2019;25:1798\u2013802.","DOI":"10.1016\/j.bbmt.2019.05.013"},{"key":"1183_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","volume":"19","author":"AM Raiola","year":"2013","unstructured":"Raiola AM, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transpl. 2013;19:117\u201322.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1183_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/leu.2012.66","volume":"26","author":"T Lion","year":"2012","unstructured":"Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R, et al. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia. 2012;26:1821\u20138.","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"1183_CR22","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1038\/bmt.2015.92","volume":"50","author":"EJ Fuchs","year":"2015","unstructured":"Fuchs EJ. HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transpl. 2015;50 Suppl 2:S31\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"1183_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/10428194.2014.930849","volume":"56","author":"C Ferr\u00e0","year":"2015","unstructured":"Ferr\u00e0 C, Sanz J, D\u00edaz-P\u00e9rez MA, Morgades M, Gayoso M, Cabrera JR, et al. Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leuk Lymphoma. 2015;56:656\u201362.","journal-title":"Leuk Lymphoma"},{"key":"1183_CR24","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/cncr.31228","volume":"124","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, G\u00fclbas 4, Koc Y, Blaise D, et al. Bone marrow versus mobilized peripheral blood stem cells, in haploidentical transplants, using post-transplant cyclophosphamide. Cancer. 2018;124:1428\u201337.","journal-title":"Cancer"},{"key":"1183_CR25","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, et al. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell\u2013replete haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol. 2017;35:3002\u20139.","journal-title":"J Clin Oncol"},{"key":"1183_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","volume":"13","author":"M Remberger","year":"2007","unstructured":"Remberger M, Watz E, Ringd\u00e9n O, Mattsson J, Shanwell A, Wikman A. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2007;13:675\u201382.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1183_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","volume":"102","author":"J Canaani","year":"2017","unstructured":"Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, et al. Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia\u2014a report from the Acute Leukemia Working Party of the EBMT. Haematologica. 2017;102:1066\u201374.","journal-title":"Haematologica"},{"key":"1183_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","volume":"14","author":"G Rond\u00f3n","year":"2008","unstructured":"Rond\u00f3n G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E, et al. Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transpl. 2008;14:859\u201366.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-01183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-01183-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-01183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:17:23Z","timestamp":1684617443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-01183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1038\/s41409-020-01183-9","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}